SYNTHESIS OF 6-AMINOPENICILLANIC ACID DERIVATIVES AND MOLECULAR DOCKING STUDY AS SARS-COV-2 MAIN PROTEASE (MPRO) INHIBITORS
The acute respiratory syndrome caused by SARS-CoV-2 is still spreading around the world. There is currently no established clinical therapy to treat COVID-19. The two parts of this study were: (1) to find Schiff base compounds generated from 6-aminopenicillanic acid (6-APA) as potential anti-viral c...
Saved in:
Main Author: | Dwiputri Aminah, Agniya |
---|---|
Format: | Final Project |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/68191 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
AMIDATION REACTION OF 6-AMINOPENICILLANIC ACID AND CYCLIC ANHYDRIDE AND IN SILICO STUDY OF ITS POTENTIAL AS INHIBITOR OF MPRO SARS-COV-2
by: Kofa, Rakatian -
VIRTUAL SCREENING OF ANTIVIRAL DRUGS AS AN INHIBITOR FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) MAIN PROTEASE (MPRO)
by: Stephen -
MOLECULAR DOCKING STUDY OF FLAVONOID COMPOUNDS AS ANTIVIRUS SARS-COV-2
by: Rizki Surgawan, Ridwan -
Phylogenetic network analysis of SARS-CoV-2 Mpro protease and the in silico screening of bioactive compounds from Philippine medicinal plants as potential Mpro inhibitors
by: Villanueva, Jose Antonio B.
Published: (2021) -
MOLECULAR DOCKING STUDIES OF XANTHONE AND CAFFEINE DERIVATIVE COMPOUNDS AS AN ANTICANCER
by: Sinebar, Wijen